Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Analysis of the Use of Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair as Long Term Follow Up to T-GENVIH-002 Study

NCT06034652 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT06034652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06034652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Analysis of the Use of Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair as Long Term Follow Up to T-GENVIH-002 Study
Lead sponsor
Integra LifeSciences Corporation
Phase
Observational
Overall status
Completed
Start date
September 12, 2023
Completion date
January 19, 2024
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hernia, hernia, abdominal, hernia, ventral, pathological conditions, anatomical